What is Elsevier's policy for off-label drug data?

You can view the relevant policies by selecting the links below:

Elsevier Editorial Policy for Off-Label Data within Drug Information Products and Databases

Elsevier Editorial Policy

Peer Review and Conflict of Interest

The Elsevier Editorial Policy governs all clinical drug data production. A peer-review process is ensured via the Editorial Policy and our electronic content management systems. Clinical Drug Information Editorial Team members have no significant financial relationships with the industry that might introduce bias in the editing or review of database content. All Editorial staff members must comply with the Elsevier Conflict of Interest Policy.